Le Lézard
Classified in: Health
Subjects: TDS, FVT

Discovery Behavioral Health Announces 'Coping With COVID,' A Free Public Webcast On April 9th With Mental Health Experts


LOS ANGELES, April 2, 2020 /PRNewswire/ -- Discovery Behavioral Health, Inc., a national leader in behavioral healthcare, will host a panel of renowned mental health experts in "Coping With COVID," two free Zoom webcasts for anyone with questions on how to cope with the stress of the global pandemic, on Thursday, April 9th beginning at 2 pm ET. The panels will address questions related to mental wellness, eating disorders, alcohol and drug addiction, and trauma.

Comprising the panel are: Lori Gottlieb, psychotherapist and The New York Times best-selling author of Maybe You Should Talk to Someone; Jenni Schaefer, Meadows Behavioral Healthcare Senior Fellow and author of Life Without Ed: How One Woman Declared Independence from her Eating Disorder and How You Can Too and an upcoming book on finding a life worth living after trauma; and comedian Dion Flynn, best known to the public for his signature impersonation of Barack Obama and his appearances on late-night network television including "The Tonight Show with Jimmy Fallon," and also founder of the Improv Recovery Workshops. Also joining the panel are Karen Rubenstein, LMFT, Chief Clinical Officer of Cliffside Malibu, Discovery's premier Southern California drug and alcohol rehabilitation center, and Deandra Christianson, MA, LCPC, CCMHC, CDWF President, Eating Disorder Division of Discovery Behavioral Health. The event moderator is George Livengood, LMFT, Division Vice President, Discovery Mood & Anxiety Program.

The April 9th online webinar is open to the public at 2 pm ET and healthcare professionals at 4 pm ET.

"Behavioral health issues do not take a break during times of crisis," said Livengood, a licensed marriage and family therapist with experience in working with both adults and adolescents. "In fact, an event of this magnitude can trigger those who are dealing with depression, anxiety, trauma or addiction. As all of us socially distance ourselves, it's a struggle for everyone to adjust to stay-at-home orders, and cope with the looming fear of illness, financial stress or job loss."

"Discovery Behavioral Health already uses Zoom technology for its telehealth patient programs nationwide, so this public program was a natural next step in its mission of leading the way in behavioral health accessibility to the public and the healthcare professionals on the front lines battling this pandemic," Livengood added.

Registration for these free events is available through Eventbrite under "Coping with COVID ? Live ZOOM Webcast." Participants can also sign up directly at these links Coping with COVID for the Public or Coping with COVID for Healthcare Professionals.

About Discovery Behavioral Health, Inc.

Discovery Behavioral Health, Inc. is a leading, in-network U.S. healthcare provider in the evidence-based treatment of substance abuse, mental health and eating disorders. It offers residential, partial hospitalization and intensive outpatient care for teens and adults. The company was established in 1998 and is headquartered in Orange County, California. More: https://www.discoverybehavioralhealth.com

Press Contact:
Greg Ptacek
PR| Communications
323-841-8002 mobile
[email protected]

 

SOURCE Discovery Behavioral Health


These press releases may also interest you

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...

at 17:49
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...

at 17:33
The American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient consumer organization in the United States, announced the overwhelming success of its 2024 "Are You O-K+" campaign, which marked May 1 (5.1) as...



News published on and distributed by: